Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / France

Strings Attached To Acomplia Reimbursement Decision

March 2007 | Company Finance Alert

French drugmaker Sanofi-Aventis ' obesity drug Acomplia (rimonabant) has been included on France's list of reimbursable medicines. The drug was initially recommended for reimbursement by the French Ministry of Health in February 2006, although it has only now been launched on the market. There has been strong opinion throughout Europe that the drug is a lifestyle medicine and should not reimbursed, with Germany an example of one country that has taken this line. As a result, although Acomplia will be reimbursed in France it will have a number of conditions attached.

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
Drug Industry Blamed For Over-Prescribing

Companies / France France's consumer association UFC-Que Choiser has claimed that over-prescribing has resulted in an unnecessary overspend on prescription medicines. While
September 2007
Acomplia Sales Disappoint

Companies / France French drugmaker Sanofi-Aventis has announced disappointing sales for its breakthrough obesity drug Acomplia (rimonabant) for Q107. In the first three months of the year, the drug only generated EUR15mn...
May 2007
OTC Market Returns To Growth

Companies / France The French OTC market was worth EUR1.8bn ((US$2.36bn) in 2006, according to recently released figures from IMS, with growth fuelled by the government's de-reimbursement policies. After receding by 3%...
March 2007
Research-based Drugmakers Feel The Pinch

Companies / France It was a tough year in 2006 for France's leading drugmakers, as government cost-cutting measures bit deeply into revenues. Although, the drug market expanded by 4%, this is lower than the growth witnessed...
March 2007
Drug Market Grows At Higher Than Expected Rate

Companies / France French medicine expenditure rose by 4% in 2006, according to recently released data from national sickness insurance fund (CNAM), despite the best efforts of the authorities to curb spending. As a result,...
March 2007
Western Europe InsightWestern Europe Channels Western Europe Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS